THORNE HOLDING CORP. AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANTCommon Stock Purchase • September 21st, 2021 • Thorne Healthtech, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 21st, 2021 Company Industry JurisdictionTHIS IS TO CERTIFY THAT, Mitsui & Co., Ltd. (the “Initial Warrant Holder”) and its successors and permitted assigns are entitled to purchase from Thorne Holding Corp., a Delaware corporation (the “Company”), at any time or from time to time after 9:00 A.M., New York City time, on October 11, 2018 (such day, the “Initial Exercise Date”), and prior to 5:00 P.M., New York City time, on the ten (10) year anniversary of the Initial Exercise Date (the “Expiration Date”), any or all of one hundred twenty-seven (127) shares (the “Initial Warrant Shares”) of Common Stock (as defined below) of the Company at a purchase price per share equal to $2,280.03 per share (the “Initial Exercise Price”). The number and character of the Initial Warrant Shares and the Initial Exercise Price are subject to adjustment as provided herein.
THORNE HOLDING CORP. AMENDED AND RESTATED COMMON STOCK PURCHASE WARRANTCommon Stock Purchase • September 21st, 2021 • Thorne Healthtech, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 21st, 2021 Company Industry JurisdictionTHIS IS TO CERTIFY THAT, Kirin Holdings Company, Limited (the “Initial Warrant Holder”) and its successors and permitted assigns are entitled to purchase from Thorne Holding Corp., a Delaware corporation (the “Company”), at any time or from time to time after 9:00 A.M., New York City time, on October 11, 2018 (such day, the “Initial Exercise Date”), and prior to 5:00 P.M., New York City time, on the ten (10) year anniversary of the Initial Exercise Date (the “Expiration Date”), any or all of one hundred twenty-seven (127) shares (the “Initial Warrant Shares”) of Common Stock (as defined below) of the Company at a purchase price per share equal to $2,280.03 per share (the “Initial Exercise Price”). The number and character of the Initial Warrant Shares and the Initial Exercise Price are subject to adjustment as provided herein.